Relevant bibliographies by topics / Arformoterol

Contents

  1. Journal articles
  2. Book chapters
  3. Conference papers

Academic literature on the topic 'Arformoterol'

Author: Grafiati
Published: 7 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Arformoterol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Arformoterol"

1

King, Paul T. "Pharmacotherapy of Chronic Obstructive Pulmonary Disease: Focus on Arformoterol Tartrate." Clinical Medicine. Therapeutics 1 (January 2009): CMT.S2584. http://dx.doi.org/10.4137/cmt.s2584.

Full text
Abstract:
Arformoterol tartrate is a newly developed long-acting ssβ2-agonist with both acute and prolonged bronchodilator effects. It is formed of 2 isomers (R,R/R,R) which distinguishes it from the more commonly used racemic formoterol (R,R/S,S). The active isomer is the (R,R) and in vitro arformoterol may have more potent anti-inflammatory effects than formoterol. It can only be given by a nebulizer. There have been 5 randomized, blinded trials which have assessed the use of arformoterol in chronic obstructive pulmonary disease (COPD). Arformoterol has been demonstrated to improve lung function and s
APA, Harvard, Vancouver, ISO, and other styles
2

&NA;. "Arformoterol." Drugs in R & D 5, no. 1 (2004): 25–27. http://dx.doi.org/10.2165/00126839-200405010-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hazra, Moumita. "A pharmacoepidemiological study of prescription patterns of β2 sympathomimetic bronchodilators in exacerbation of non-severe asthma in tertiary care hospitals, not needing hospitalization". International Journal of Basic & Clinical Pharmacology 8, № 12 (2019): 2674. http://dx.doi.org/10.18203/2319-2003.ijbcp20195276.

Full text
Abstract:
Background: Arformoterol, the (R, R) enantiomer of the racemic (R, R / S, S) diastereomer, formoterol, is a short and long acting β2 agonist bronchodilator. Levosalbutamol, the (R, R) enantiomer of racemic diastereomer (R, R / S, S) salbutamol, has a greater affinity for the β2 receptor. Occupation of β2 receptors by agonists result in the activation of the Gs-adenylyl cyclase-cAMP-PKA pathway, followed by phosphorylative events leading to bronchial smooth muscle relaxation. The aim of this pharmacoepidemiological study was to analyse the prescription patterns, and prescription content analysi
APA, Harvard, Vancouver, ISO, and other styles
4

Cada, Dennis J., Terri Levien, and Danial E. Baker. "Arformoterol Tartrate." Hospital Pharmacy 42, no. 5 (2007): 447–54. http://dx.doi.org/10.1310/hpj4205-447.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Revill, P., N. Serradell, J. Bolós, and M. Bayés. "Arformoterol Tartrate." Drugs of the Future 31, no. 11 (2006): 944. http://dx.doi.org/10.1358/dof.2006.031.11.1047743.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Arformoterol comparable to salmeterol for COPD." Inpharma Weekly &NA;, no. 1558 (2006): 6. http://dx.doi.org/10.2165/00128413-200615580-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cazzola, Mario, Nicola A. Hanania, and Maria G. Matera. "Arformoterol tartrate in the treatment of COPD." Expert Review of Respiratory Medicine 4, no. 2 (2010): 155–62. http://dx.doi.org/10.1586/ers.10.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bhutnar, Arun, Anita Desai, Sachin Khapare, Sonali Vartak, Ajay Pangavhane, and Allwyn Andrandes. "Identification and Structural Characterization of Secondary Degradant of Arformoterol Impurity in LDPE Respules of Arformoterol Tartrate Inhalation Solution." American Journal of Analytical Chemistry 09, no. 05 (2018): 286–301. http://dx.doi.org/10.4236/ajac.2018.95022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

King, Paul. "Role of arformoterol in the management of COPD." International Journal of Chronic Obstructive Pulmonary Disease Volume 3 (September 2008): 385–91. http://dx.doi.org/10.2147/copd.s753.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jeong, Jin-Hyuk, Jaewoon Son, Ji-Hyeon Kwon, Chang-Soo Han, and Chun-Woong Park. "Impact of Different Hydrate Forms of Magnesium Stearate as a Flow Control Agent on the Physical Stability and Inhalation Efficiency of Carrier-Based Formulations." Pharmaceutics 17, no. 6 (2025): 711. https://doi.org/10.3390/pharmaceutics17060711.

Full text
Abstract:
Objectives: This study aimed to evaluate the impact of the different hydration states of magnesium stearate (Mg.st) anhydrate (AH), monohydrate (MH), and dihydrate (DH) on the aerodynamic performance and stability of carrier-based dry powder inhalation (DPI) formulations using arformoterol and budesonide as model drugs. Methods: DPI formulations were prepared using Inhalac 251 lactose and Mg.st in various hydrated forms. The physicochemical properties of Mg.st were characterized using powder X-ray diffraction, differential scanning calorimetry, Fourier-transform infrared spectroscopy, Karl Fis
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Arformoterol"

1

"ARFORMOTEROL." In Litt's Drug Eruptions & Reactions Manual. CRC Press, 2010. http://dx.doi.org/10.3109/9781841847665-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"Arformoterol." In Hale’s Medications & Mothers’ Milk™ 2019. Springer Publishing Company, 2018. http://dx.doi.org/10.1891/9780826150356.0063.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Arformoterol"

1

Panettieri, R., J. Walsh, M. Sims та ін. "Comparison of Efficacy and Safety of Arformoterol 15 μg Twice Daily with Arformoterol 30 μg Once Daily in Patients with COPD." У American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4542.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Karafilidis, John, Noelle Wilson, and Kenneth Sciarappa. "Evaluation Of Efficacy Following Arformoterol Tartrate 15 µg And Formoterol Fumarate 12 µg In Patients With Moderate To Severe COPD Stratified By Baseline Inspiratory Capacity." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sciarappa, Kenneth, and John Karafilidis. "An Evaluation Of Response Rates Following Treatment With Nebulized Arformoterol 15 µg, Salmeterol MDI 42 µg Or Placebo Twice Daily In Patients With Moderate COPD." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1588.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Karafilidis, John. "By Age Evaluation Of Efficacy And Safety Following Treatment With Nebulized Arformoterol 15 G, Salmeterol 42 G MDI And Placebo Twice Daily In Patients With Moderate COPD." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1587.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bauer, Andrea, Jay Holt, Eric Stewart, et al. "In Vitro Analysis Of The Effect Of Air Flow Rate On The Aerosol Properties Of Nebulized Arformoterol And Tiotropium And Fluticasone/Salmeterol Delivered Via Dry Powder Inhalers." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1601.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Arformoterol' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography